BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3963868)

  • 1. Oral desmopressin in central diabetes insipidus.
    Westgren U; Wittström C; Harris AS
    Arch Dis Child; 1986 Mar; 61(3):247-50. PubMed ID: 3963868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
    Rampazzo AL; Boscaro M; Mantero F; Piccitto R
    Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
    Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
    Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
    Arima H; Oiso Y; Juul KV; Nørgaard JP
    Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A; Czernichow P
    Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral desmopressin treatment of central diabetes insipidus in children.
    Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
    Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
    Fjellestad-Paulsen A; Crosnier H; Czernichow P
    Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
    Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
    J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
    Fukuda I; Hizuka N; Takano K
    Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.